How Long Do HPV Vaccine Side Effects Last?

Most HPV vaccine side effects are mild and resolve within a few days. The most common reaction, injection-site pain, lasts a median of about two days, and the vast majority of local reactions clear up within five days of the shot. Systemic effects like fatigue, headache, and low-grade fever follow a similar short timeline. The picture gets more nuanced when you look at rarer reactions and the long-running safety questions that have generated public concern, but the core answer holds: for the overwhelming majority of people, any discomfort from the HPV vaccine is brief.

Injection-Site Soreness Is the Most Common Reaction

Pain at the spot where the needle went in is far and away the most frequently reported side effect. In a study of parents reporting on their daughters’ experiences, about two-thirds said their child had some pain or discomfort after the shot, though only a small fraction described it as moderate or severe. The pain that lingered in the hours and days after injection lasted a median of 48 hours, with a wide range from as little as one hour up to about two weeks in uncommon cases.¹

A separate post-hoc analysis of clinical trial participants in Japan found that most injection-site reactions showed up within three days and were mild to moderate in intensity. Roughly 88% of those reactions resolved within five days of onset, and all of them eventually cleared. Severe injection-site reactions occurred in only about 2% of vaccine recipients.²

Along with pain, swelling and redness at the injection site are commonly reported. A systematic review found that pain, swelling, and redness were the top three local reactions across HPV vaccine trials, with pain being the standout.³ These reactions behave like what you would expect from any intramuscular injection: redness and swelling tend to peak within a day or two and fade over roughly the same timeline as the pain. Applying a cool compress or taking a standard over-the-counter pain reliever can help, though most people find the discomfort manageable without any intervention.

Systemic Symptoms and Their Typical Timeline

Beyond what happens at the injection site, some people experience whole-body symptoms like fatigue, headache, mild fever, nausea, and muscle aches. The same systematic review that cataloged local reactions found fatigue to be the most relevant general side effect, followed by fever, gastrointestinal symptoms, and headache.³ These tend to show up within the first day or two after vaccination and typically resolve within 24 to 72 hours.

Fever, when it appears, is usually low-grade and short-lived. Nausea and headache similarly pass quickly. It is worth noting that these kinds of systemic reactions are not unique to HPV vaccines; they are standard features of many vaccines and reflect your immune system mounting a response. The distinction that matters for the reader: these are transient signals of immune activation, not signs of illness caused by the vaccine.

Fainting After the Shot

Syncope, or fainting, is one of the more dramatic side effects associated with HPV vaccination, but it is not really a drug reaction in the traditional sense. It happens because of a vasovagal response to the needle, the brief pain, or the anxiety surrounding the injection, and it occurs with many types of shots and blood draws. It is particularly common in adolescents and young adults.

A large study that examined vaccination records found the rate of postvaccination syncope was about 3 per 10,000 vaccination events.⁴ The faint itself is brief and typically happens within minutes of the injection. The real risk is not the fainting episode but the potential for injury from falling. That is why vaccination sites routinely ask you to sit or lie down for 15 minutes afterward. In the parent-reported study mentioned earlier, no parents reported syncope among their daughters, though about 3% said their child felt dizzy or light-headed.¹

School-based vaccination campaigns can sometimes produce cluster events where several students faint or feel unwell around the same time. Research into these episodes has consistently pointed to anxiety-related reactions and hyperventilation rather than any pharmacological effect of the vaccine. In one documented cluster among adolescent schoolgirls in India, the symptoms resolved rapidly, and imaging and lab results were unremarkable.⁵ These events can look alarming but are fundamentally about the setting and the stress of the moment, not the vaccine formula.

Severe Allergic Reactions

Anaphylaxis following HPV vaccination has been documented but is extremely rare. When it does occur, it happens within minutes of the injection, which is part of why providers ask you to wait in the office after any vaccination. A review of anaphylaxis cases after the quadrivalent HPV vaccine found that overall rates were very low and that cases were managed appropriately with no lasting harm.⁶

If you have had anaphylaxis to a previous dose of any HPV vaccine or to any of its components, you should not receive another dose, and your provider will know to screen for that. For everyone else, the practical takeaway is that the risk is vanishingly small, and the brief observation period after vaccination is a well-tested safety net.

How Different HPV Vaccines Compare on Side Effects

Three HPV vaccines have been used globally: the bivalent (Cervarix), the quadrivalent (Gardasil), and the nine-valent (Gardasil 9). In most countries today, the nine-valent vaccine is the one in active use. The side-effect profiles across these formulations are broadly similar in type and duration, but there are some differences in intensity that trace back to their formulations.

Cervarix uses an adjuvant system that includes monophosphoryl lipid A in addition to aluminum, whereas the Gardasil vaccines use an aluminum-based adjuvant alone. Lab research has shown that this difference translates into meaningfully different inflammatory signaling: Cervarix triggered stronger expression of certain inflammatory markers in immune cells compared to Gardasil, which produced a milder inflammatory profile.⁷ The systematic review of clinical trials reflected this in practice, finding that the bivalent vaccine (Cervarix) was associated with somewhat more reported adverse effects than the quadrivalent formulation, though the review authors noted that more trials had evaluated the bivalent vaccine, which could contribute to the difference.³

For practical purposes, none of these differences change the overall picture: the side effects from all HPV vaccine formulations are overwhelmingly short-lived and mild. If you received a Cervarix dose and had a rougher day or two than a friend who got Gardasil, the adjuvant difference is a plausible explanation.

What About the Aluminum Adjuvant and Longer-Lasting Inflammation

One concern that surfaces in online discussions is whether the aluminum adjuvant in HPV vaccines causes persistent local inflammation or broader systemic effects. There is a documented pathological finding called macrophagic myofasciitis, where a small granuloma of immune cells persists at the injection site, sometimes detectable on biopsy months or even years later. A critical evaluation of the evidence found that this type of localized reaction is just a normal trace of the body’s response to aluminum-containing vaccines and does not cause systemic inflammation or diverse symptoms elsewhere in the body.⁸

In other words, even if a microscopic immune response persists at the injection site longer than you can feel it, this does not translate into ongoing symptoms. The ache you feel for two days is the part of the immune response that involves you. The rest is housekeeping your body does on its own.

Long-Term Safety and Autoimmune Concerns

Perhaps the most persistent public worry about HPV vaccines involves long-term conditions, particularly autoimmune diseases and neurological disorders. Reports of conditions like chronic fatigue, complex regional pain syndrome, and postural tachycardia syndrome following HPV vaccination have circulated online and been taken seriously enough by researchers and regulatory agencies to warrant formal investigation.

The findings have been reassuring. The American Autonomic Society reviewed the evidence and concluded that there are no data supporting a causal relationship between HPV vaccination and these conditions. The World Health Organization’s Global Advisory Committee on Vaccine Safety similarly found no causal association after evaluating large population-based datasets from multiple countries.⁹ A separate systematic review and meta-analysis looking specifically at autoimmune disorders found no correlation between HPV vaccines and autoimmune disease overall.¹⁰

Large-scale safety monitoring through the U.S. Vaccine Safety Datalink, which tracked over 600,000 HPV vaccine doses, found no statistically significant increased risk for the outcomes studied. The one signal that drew attention was a non-significant elevation in venous blood clot codes among younger girls, but when researchers pulled the actual medical records, all confirmed cases had known independent risk factors like oral contraceptive use, clotting disorders, or obesity.¹¹ This is a good example of how careful safety surveillance works: a statistical blip gets noticed, but digging into it reveals that the vaccine was not the cause.

Broader passive surveillance through the U.S. Vaccine Adverse Event Reporting System over 18 years of HPV vaccination has consistently shown that the overwhelming majority of reported adverse events are not serious.¹² By the time reporting had accumulated through 2014, over 67 million doses had been administered in the U.S. alone, and about 92% of the adverse events reported to VAERS were classified as not serious. The most common reports were fainting, injection-site reactions, dizziness, nausea, and headache.¹³

HPV Vaccine and Pregnancy

Because HPV vaccination is recommended in adolescence and young adulthood, some people end up receiving a dose around the time they become pregnant, either inadvertently or because they did not yet know they had conceived. This has naturally raised questions about whether the vaccine could affect pregnancy outcomes.

A large matched study in Denmark compared pregnancy outcomes between women exposed to the quadrivalent HPV vaccine during pregnancy and unexposed women. There was no significantly higher risk of major birth defects, spontaneous abortion, preterm birth, low birth weight, small size for gestational age, or stillbirth among the vaccinated group.¹⁴ Similarly, long-term follow-up data from the Costa Rica HPV Vaccine Trial found no evidence that the bivalent HPV vaccine affected miscarriage risk, even for pregnancies conceived within 90 days of vaccination.¹⁵ Information from the manufacturer’s pregnancy registry and clinical trials has also shown no increased risk of fetal malformations.¹⁶

Current guidance still recommends against deliberately vaccinating during pregnancy, mainly because the data, while reassuring, come from women who were vaccinated incidentally rather than from randomized trials designed to test safety in pregnancy. If you received a dose and later found out you were pregnant, the evidence does not point to any cause for concern. The remaining doses can simply be completed after delivery.

When to Contact a Provider

Given the timeline above, you can generally expect any soreness, fatigue, or mild fever to resolve on its own within a few days without medical attention. A few situations do warrant a call to your healthcare provider:

Persistent pain: If injection-site pain lasts more than a week or worsens after the first few days rather than improving, it is worth having it checked.
High fever: A temperature that exceeds about 101.3°F (38.5°C) or persists beyond two days is unusual and should be evaluated.
Allergic symptoms: Hives, swelling of the face or throat, difficulty breathing, or rapid heartbeat within minutes to hours after the shot require immediate medical attention.
Unusual neurological symptoms: Significant weakness, numbness, or vision changes in the days after vaccination are not expected side effects and should be reported to a provider promptly.

None of these situations are common, but knowing what falls outside the normal range can save you unnecessary worry over ordinary post-vaccine soreness while alerting you to the rare scenario that needs attention.

Talking to Hesitant Family Members

If you are navigating HPV vaccine decisions for yourself or a teenager, you may encounter resistance from family members or friends who have read alarming accounts online. Research into vaccine communication has found that parents who express concerns about HPV vaccine safety often need more than a quick reassurance; providers may need longer, more engaged conversations to address those concerns effectively.¹⁷ The same principle applies to conversations at home.

The strongest cards to play are the specific numbers: hundreds of millions of doses administered globally, two decades of active surveillance, and a consistent finding across multiple independent research groups and countries that serious long-term effects have not materialized. The side effects that do happen are well-characterized, mild, and over within days. The cancers the vaccine prevents, on the other hand, are not.

1
PubMed Central. How much will it hurt? HPV vaccine side effects and influence on completion of the three-dose regimen – Section: 3.1. Reported vaccine pain
2
PubMed Central. Post-hoc analysis of injection-site reactions following vaccination with quadrivalent human papillomavirus vaccine in Japanese female clinical trial participants
3
PubMed Central. Safety, tolerability and side effects of human papillomavirus vaccines: a systematic quantitative review
4
PubMed Central. Incidence of Adolescent Syncope and Related Injuries Following Vaccination and Routine Venipuncture
5
PubMed Central. Transient neuropsychiatric events after HPV vaccination among adolescent schoolgirls in India
6
PubMed Central. Anaphylaxis following quadrivalent human papillomavirus vaccination
7
PubMed. HPV vaccines induce trained immunity and modulate pro-inflammatory cytokine expression in response to secondary Toll-like receptor stimulations
8
PubMed Central. Critical evaluation on roles of macrophagic myofasciitis and aluminum adjuvants in HPV vaccine-induced adverse events
9
Autonomic Neuroscience. Evaluation of the relation between human papillomavirus vaccination and autonomic disorders
10
PubMed Central. HPV vaccine and autoimmune diseases: systematic review and meta-analysis of the literature
11
PubMed. Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink
12
PubMed Central. Real-world safety of HPV vaccines over 18 y: A comprehensive analysis of U.S. VAERS reports
13
PubMed Central. Pros, cons, and ethics of HPV vaccine in teens—Why such controversy?
14
PubMed. Quadrivalent HPV Vaccination and the Risk of Adverse Pregnancy Outcomes
15
PubMed Central. Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial
16
PubMed Central. Human papillomavirus vaccine and pregnancy
17
American Academy of Pediatrics (Pediatrics). Questions and Concerns About HPV Vaccine: A Communication Experiment